//fpnotebook.com/
Haloperidol
Aka: Haloperidol, Haldol, Haloperidol Lactate, Haloperidol decanoate- See Also
- Indications
- Psychosis
- Delirium
- Schizophrenia
- Tic Disorders (including Tourette's Syndrome)
- Acute Mania
- Contraindications
- Pregnancy and Lactation
- Phencyclidine (PCP) Overdose
- Anticholinergic Syndromes
- Alcohol or Benzodiazepine Withdrawal
- Hepatic Insufficiency
- Neuroleptic Malignant Syndrome
- Class
- First Generation Antipsychotic
- Dosing: Haloperidol
- Dose
- Adult: 5-10 mg PO, IM, or IV
- Peds: 0.5-1 mg PO, IM or IV
- Adolescent: 1-5 mg PO, IM or IV
- Elderly: 0.5-2 mg PO, IM or IV
- Intervals: Scheduled and repeated dosing intervals
- May repeat every 30-60 minutes
- Maximum: 300 mg/24 hours (avoid cummulative dose over 100 mg in 24 hours)
- May dose regularly every 6-8 hours
- Typical effective dose: 5 mg PO, IV, or IM tid (lower doses in the elderly)
- Total dose >3 mg/day is associated with Extrapyramidal Side Effects
- Dose
- Dosing: Haloperidol decanoate (depot form)
- Haloperidol decanoate 100 mg IM every 4 weeks
- Cost effective (may be as low as $19 generic)
- Precautions
- Intravenous doses have a much shorter duration of action than other routes
- Antipsychotics are associated with increased mortality in the elderly
- Adverse effects
- Serious
- See Extrapyramidal Side Effects (EPSE)
- Neuroleptic Malignant Syndrome
- Hypotension
- Dystonia
- Seizures
- Prolonged QT interval
- Risk of Torsades de Pointes
- Dose related effect with higher risk at higher doses
- Common
- Insomnia
- Restlessness
- Anxiety
- Sedation
- Headache
- Weight gain
- Hyperprolactinemia
- Blood dyscrasia
- Serious
- Monitoring
- Serum Prolactin
- Obtain if indicated
- Complete Blood Count (indicated if history of Leukopenia)
- Baseline
- Monthly in first 3 months of therapy
- Serum Prolactin
Medication Costs | ||
---|---|---|
Haloperidol (on 6/18/2017 at Walmart.com) | ||
Haloperidol 0.5mg | #30 tablets for $4.00 | $0.13 each |
Haloperidol 0.5mg | #90 tablets for $10.00 | $0.11 each |
Haloperidol 1mg | #30 tablets for $4.00 | $0.13 each |
Haloperidol 1mg | #90 tablets for $10.00 | $0.11 each |
Haloperidol 2mg | #30 tablets for $4.00 | $0.13 each |
Haloperidol 2mg | #90 tablets for $10.00 | $0.11 each |
Haloperidol 5mg | #30 tablets for $4.00 | $0.13 each |
Haloperidol 5mg | #90 tablets for $10.00 | $0.11 each |
haloperidol (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
HALOPERIDOL 0.5 MG TABLET | Generic | $0.22 each |
HALOPERIDOL 1 MG TABLET | Generic | $0.27 each |
HALOPERIDOL 10 MG TABLET | Generic | $0.57 each |
HALOPERIDOL 2 MG TABLET | Generic | $0.35 each |
HALOPERIDOL 20 MG TABLET | Generic | $1.38 each |
HALOPERIDOL 5 MG TABLET | Generic | $0.45 each |
HALOPERIDOL LAC 2 MG/ML CONC | Generic | $0.06 per ml |
HALOPERIDOL LAC 5 MG/ML VIAL | Generic | $0.79 per ml |
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. |
Haloperidol (C0018546) |
|
---|---|
Definition (MSH) | A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) |
Definition (NCI_NCI-GLOSS) | A drug used to treat certain mental and neurological disorders. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of antiemetic and a type of antipsychotic. |
Definition (NCI) | A phenylbutylpiperadine derivative with antipsychotic, neuroleptic, and antiemetic activities. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain, thereby eliminating dopamine neurotransmission and leading to antidelusionary and antihallucinagenic effects. Antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) accounts for its antiemetic activity. |
Definition (CSP) | USP lists as an antipsychotic and as an "antidyskinetic" used in Tourette syndrome. |
Definition (PDQ) | A phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain, thereby eliminating dopamine neurotransmission and leading to antidelusionary and antihallucinagenic effects. The antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) accounts for its antiemetic activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39474&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39474&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C537" NCI Thesaurus) |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | D006220 |
SnomedCT | 321415008, 323259009, 10756001, 386837002 |
LNC | LP16158-5, MTHU005005 |
English | Haloperidol, 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-, Haloperidol [antipsychotic], Haloperidol [tics, chorea], Haloperidol [tics, chorea] [see D47..], 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, HALOPERIDOL, haloperidol (medication), Haloperidol [Chemical/Ingredient], Haloperidol [tics, chorea] [see D47..] (product), Haloperidol [antipsychotic] (product), haloperidol, Haloperidol (product), Haloperidol (substance), Haloperidol [antipsychotic] (substance), Haloperidol [tics, chorea] [see D47..] (substance) |
Swedish | Haloperidol |
Czech | haloperidol |
Finnish | Haloperidoli |
Russian | GALOPERIDOL, ГАЛОПЕРИДОЛ |
Japanese | ハロペリドール |
Croatian | HALOPERIDOL |
Polish | Haloperidol |
Spanish | haloperidol [tics, corea] [véase D47..] (producto), haloperidol [antipsicótico], haloperidol [tics, corea] [véase D47..], haloperidol [antipsicótico] (producto), haloperidol (producto), haloperidol (sustancia), haloperidol, Haloperidol |
French | Halopéridol |
German | Haloperidol |
Italian | Aloperidolo |
Portuguese | Haloperidol |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
haloperidol decanoate (C0062103) |
|
---|---|
Definition (NCI) | The decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain leading to anti-delusionary and anti-hallucinogenic effects. The antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) account for its antiemetic activity. |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | C033563 |
SnomedCT | 412196004, 321699007 |
English | haloperidol decanoate, Haloperidol Decanoate, Haloperidol deconoate, haloperidol decanoate (discontinued) (medication), haloperidol decanoate (discontinued), haloperidol decanoate [Chemical/Ingredient], HALOPERIDOL DECANOATE, Haloperidol decanoate, Haloperidol decanoate (product), Haloperidol decanoate (substance), Haloperidol deconoate (substance) |
Spanish | decanoato de haloperidol (producto), decanoato de haloperidol, decanoato de haloperidol (sustancia) |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Haldol (C0591585) |
|
---|---|
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | D006220 |
English | Haldol, haldol |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Haloperidol lactate (C0720809) |
|
---|---|
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
SnomedCT | 412197008 |
English | haloperidol lactate, haloperidol lactate (medication), Haloperidol lactate, HALOPERIDOL LACTATE, Haloperidol Lactate, Haloperidol lactate (substance) |
Spanish | lactato de haloperidol (sustancia), lactato de haloperidol |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.